Life SciencesLiability
Get a quote

TL;DR

Puerto Rico is one of the largest pharmaceutical and medical-device manufacturing hubs in the US system, and its facilities carry a distinctive catastrophe profile from hurricane and named-windstorm exposure. Programs here pair cGMP-aligned property with validation-loss coverage and robust business interruption against products and completed-operations liability tied to sponsor MSAs, plus cargo and stock-throughput for material in custody and transit.

Puerto Rico pharma & device manufacturing

Insurance for Puerto Rico Pharmaceutical & Medical-Device Manufacturers

Puerto Rico anchors a long-established base of FDA-registered drug, biologics, and medical-device manufacturing, and it remains a major exporter of finished pharmaceuticals and devices within the US system. Operations on the island typically produce for outside sponsors under manufacturing and supply agreements, which means the insurance program has to answer both to a demanding cGMP operating environment and to the specific contract-insurance schedules those sponsors require. The result is a program that looks less like a general-manufacturing policy and more like a purpose-built life-sciences architecture.

What sets Puerto Rico apart from mainland manufacturing clusters is the concentration of catastrophe exposure. Hurricane and wind risk raise the stakes on property and business-interruption coverage in a way that shapes the entire placement, from named-windstorm terms to contingent business interruption where a single facility supports critical sponsor supply. We structure programs so that a validated, cGMP-qualified facility can survive a catastrophe event without an uninsured gap between physical damage, lost production, and the contractual liabilities owed to sponsors.

Get a quoteRun the Free Analyzer

Last updated 2026-07-13

Cluster shape

A concentrated manufacturing hub with a distinctive catastrophe profile

Puerto Rico has hosted FDA-registered drug, biologics, and device manufacturing for decades, and it operates as one of the largest pharmaceutical and medical-device production centers in the US system. That density means many facilities run high-value, validated production lines that supply sponsors on the mainland and abroad, so the economic exposure behind a single plant can be substantial.

The finished goods made here span small-molecule drugs, biologics, and medical devices, frequently under contract for sponsor companies rather than for the manufacturer's own label. This contract-manufacturing posture drives the liability side of the program, because the completed drugs and devices carry products exposure that the manufacturing agreement then allocates between the site and its sponsors.

The defining local factor is catastrophe risk. Hurricane and named-windstorm exposure make property and business-interruption coverage the center of gravity for Puerto Rico programs, and they force careful attention to named-windstorm sublimits, deductibles, and the interplay between physical damage and lost production at a validated facility.

Coverage architecture

How we structure coverage for Puerto Rico manufacturers

The property program is built around cGMP-aligned coverage with validation-loss protection, so that rebuilding after a loss accounts for the requalification and revalidation a regulated line requires, not just the replacement of equipment. Because catastrophe exposure is the distinctive Puerto Rico factor, we pair that property with robust business interruption, evaluate contingent business interruption where sponsor supply depends on a single site, and scrutinize named-windstorm terms, sublimits, and deductibles rather than treating them as boilerplate.

On the liability side, products and completed-operations coverage responds to the finished drugs and devices manufactured for sponsors, and it is sized to the contract-insurance schedules those sponsors impose. Cargo and stock-throughput coverage protects material in the manufacturer's custody and in transit, which matters on an island where raw material, work in process, and finished goods move through extended logistics chains.

Sponsor manufacturing and supply agreements set the contractual insurance requirements the program must satisfy, including additional-insured status, primary and non-contributory wording, waivers of subrogation, and specific limit thresholds. We map each sponsor MSA insurance schedule against the placement so the certificates and endorsements actually match what the contracts demand, closing the gaps that otherwise surface only after a claim. Coverage limits are placed as market-typical ranges calibrated to facility values, sponsor requirements, and catastrophe modeling rather than a single fixed number.

Regulatory + market context

The cGMP framework behind the underwriting

FDA current good manufacturing practice requirements, including 21 CFR Parts 210 and 211 for drug products, define the operating standard these facilities are held to and shape how underwriters view the risk. A site's quality systems, validation records, and inspection history inform property, products, and recall-related terms, because a cGMP deviation can drive both regulatory and liability consequences.

Because the cGMP framework governs how products are made, released, and documented, it is inseparable from the insurance analysis. We align the program to the regulatory posture of the facility, so that validation-loss property coverage, products liability, and the sponsor-required schedules all reflect the same compliance reality the FDA framework establishes.

Frequently asked

Common questions from Puerto Rico pharma & device manufacturing operators

What makes insurance for Puerto Rico pharmaceutical and device manufacturing distinct?

Two things: scale and catastrophe exposure. Puerto Rico is one of the largest pharmaceutical and medical-device manufacturing hubs in the US system, so facilities carry high-value, validated production and significant products exposure on goods made for sponsors. On top of that, hurricane and named-windstorm risk make property and business-interruption coverage far more consequential than at a comparable mainland site, which reshapes the entire placement.

Why do property, business interruption, and named-windstorm terms matter so much for a cGMP facility here?

A validated cGMP line is expensive to rebuild and slow to requalify, so a catastrophe loss threatens not only equipment but months of interrupted, revenue-generating production. We structure cGMP-aligned property with validation-loss coverage and robust business interruption, and we pay close attention to named-windstorm sublimits, deductibles, and contingent business interruption where a single facility underpins critical sponsor supply. The goal is to avoid an uninsured gap between physical damage, lost production, and the obligations owed under sponsor contracts.

How do sponsor MSAs drive the liability schedule?

Manufacturing and supply agreements dictate the contractual insurance a site must carry, typically including additional-insured status, primary and non-contributory wording, waivers of subrogation, and specific limit requirements tied to the products and completed operations for that sponsor. We read each MSA insurance schedule and align the program's limits, endorsements, and certificates to it, so the coverage matches the contract instead of leaving exposure that only appears at claim time.

Is sponsor-supplied material in custody and transit covered?

Yes. Cargo and stock-throughput coverage protects material in the manufacturer's custody and while in transit, which is important given the extended logistics chains that serve island operations. This addresses raw material, work in process, and finished goods, and it can be coordinated with the sponsor MSA where the agreement assigns responsibility for material owned by the sponsor but held or moved by the manufacturer.

CDMO insurance practice →cGMP property & validation loss →Medical device insurance practice →Evaluate a sponsor MSA →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for Puerto Rico pharma & device manufacturing operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.